These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29615658)

  • 1. Systemic IGF-1 gene delivery by rAAV9 improves spontaneous autoimmune peripheral polyneuropathy (SAPP).
    Gao T; Bogdanova N; Ghauri S; Zhang G; Lin J; Sheikh K
    Sci Rep; 2018 Apr; 8(1):5408. PubMed ID: 29615658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.
    Yalvac ME; Arnold WD; Braganza C; Chen L; Mendell JR; Sahenk Z
    Gene Ther; 2016 Jan; 23(1):95-102. PubMed ID: 26125608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
    Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
    Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
    Quan S; Sheng JR; Abraham PM; Soliven B
    Clin Exp Immunol; 2016 Apr; 184(1):50-61. PubMed ID: 26671281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy.
    Huehnchen P; Boehmerle W; Endres M
    Sci Rep; 2018 Apr; 8(1):5648. PubMed ID: 29618748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment.
    Allard DE; Wang Y; Li JJ; Conley B; Xu EW; Sailer D; Kimpston C; Notini R; Smith CJ; Koseoglu E; Starmer J; Zeng XL; Howard JF; Hoke A; Scherer SS; Su MA
    J Clin Invest; 2018 Oct; 128(10):4727-4741. PubMed ID: 30222134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Insulin-like growth factor-1 reverses hypoalgesia and improves mobility in a mouse model of diabetic peripheral neuropathy.
    Chu Q; Moreland R; Yew NS; Foley J; Ziegler R; Scheule RK
    Mol Ther; 2008 Aug; 16(8):1400-8. PubMed ID: 18545223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune mechanisms in spontaneously occurring CIDP in NOD mice.
    Soliven B
    J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():56-9. PubMed ID: 21696501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of activating Fcγ receptors in spontaneous autoimmune peripheral polyneuropathy model protects from neuropathic disease.
    Zhang G; Bogdanova N; Gao T; Sheikh KA
    PLoS One; 2019; 14(8):e0220250. PubMed ID: 31415574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model.
    Ubogu EE; Yosef N; Xia RH; Sheikh KA
    J Peripher Nerv Syst; 2012 Mar; 17(1):53-61. PubMed ID: 22462666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
    Haq RU; Pendlebury WW; Fries TJ; Tandan R
    Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune neuropathies: insights from animal models.
    Soliven B
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():28-33. PubMed ID: 22548620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High salt diet ameliorates functional, electrophysiological and histological characteristics of murine spontaneous autoimmune polyneuropathy.
    Huehnchen P; Boehmerle W; Endres M
    Neurobiol Dis; 2019 Apr; 124():240-247. PubMed ID: 30468863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Dyck PJB; Tracy JA
    Mayo Clin Proc; 2018 Jun; 93(6):777-793. PubMed ID: 29866282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve ultrasound can distinguish chronic inflammatory demyelinating polyneuropathy from demyelinating diabetic sensorimotor polyneuropathy.
    Tan CY; Arumugam T; Razali SNO; Yahya MA; Goh KJ; Shahrizaila N
    J Clin Neurosci; 2018 Nov; 57():198-201. PubMed ID: 30145079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
    Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
    Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.